Sonicates from unstimulated human neutrophils produce no measurable superoxide since the superoxide-generating enzyme, NADPH oxidase, is inactive in these preparations. Previous attempts to activate the oxidase in disrupted cells with conventional neutrophil stimuli have been unsuccessful. This report describes a cell-free system in which arachidonic acid (82 M1M) was able to activate superoxide generation that was dependent upon the presence of NADPH and the sonicate. For activation to occur, both the particulate and supernatant fractions of the sonicate must be present. Calcium ions, which are required for activation of intact neutrophils by arachidonate, were not necessary in the cell-free system. In quantitative terms, the superoxide-generating activity in the cell-free system could account for at least 20-50% of the superoxide rate observed in intact neutrophils stimulated with arachidonate.
Introduction
When neutrophils phagocytize opsonized microorganisms, they exhibit a several 100-fold increase in oxygen consumption with concomitant superoxide generation (1, 2) . The central event in the activation of this respiratory burst is the conversion of a membrane-bound NADPH oxidase from an inactive to an active form (1) . Once activated, the oxidase can catalyze the one-electron reduction of oxygen to superoxide. the intact cell level have been frustrated by the complexity of the biochemical and cellular changes that occur during phagocytosis. Ideally, NADPH oxidase activation would best be approached using a cell-free system in which the constituents of the activation reaction could be carefully controlled. For reasons that are not clear, however, it has not been possible to activate the oxidase once unstimulated neutrophils have been disrupted. Recently, arachidonic acid has been found to be a potent stimulus of the respiratory burst (3) (4) (5) in intact cells. This agent has the unique property of causing activation of the respiratory burst without the lag time characteristic of other neutrophil stimuli, suggesting that arachidonic acid might enter the activation pathway at some distal point and might, therefore, activate the oxidase in disrupted neutrophils. This report describes a cell-free system in which NADPH oxidase from unstimulated human neutrophils was activated by arachidonic acid. In addition, the effect of arachidonic acid on disrupted neutrophils from patients with chronic granulomatous disease (CGD)' is reported. Concurrent with the development of the cell-free system in this laboratory, both McPhail et al. (6) 
Results
Activation of unstimulated neutrophil sonicates with arachidonic acid. Table I shows the effect of arachidonic acid on superoxide generation by neutrophil sonicates. Before the addition of arachidonate, no superoxide generation was measured. However, within several seconds after the addition of arachidonic acid, a substantial rate of superoxide production was noted that continued at a linear rate until all of the NADPH was consumed (data not shown). This result indicated that arachi- Changes in intracellular concentrations of ionized calcium have been proposed to play a role in the regulation of oxidase activity (12) (13) (14) . Since the experiments described above were all performed with buffers and reagents prepared without calcium, the results suggest that activation of the oxidase does not require calcium when arachidonic acid is the stimulus. To exclude more rigorously the involvement of calcium in the activation process, 10 mM EGTA was incorporated into both the PBS used for cell disruption and the buffers used in the superoxide assay. As shown in Table II , the presence of 10 mM EGTA had no inhibitory effect on oxidase activation. Superoxide generation by sonicate fractions from normal and CGD neutrophils. Neutrophils from CGD patients fail to undergo a respiratory burst in response to all known neutrophil stimuli. The failure to activate the respiratory burst in CGD is believed to be due either to a defective NADPH oxidase or to a defective activation pathway. It was of interest to examine the sonicates from CGD neutrophils for two reasons. First, failure to detect superoxide production in the cell-free system would provide confirmatory evidence that arachidonate does, in fact, activate NADPH oxidase to make superoxide. Second, it would be possible to determine whether the soluble component in the supernate was defective in CGD or whether the pellet material was abnormal (or both). The results of these experiments are shown in Table III . In these studies, supernate from either normal or CGD neutrophils was mixed in different combinations with pellet material from normal and CGD cells. Three different CGD patients were examined in these experiments, two of whom had the X-linked form of CGD, while the third patient had the autosomal recessive form. The control mixture, in which normal supernate and pellet were mixed together, showed the expected rate of superoxide generation. When both the supernate and pellet fractions were derived from CGD neutrophils, no superoxide was generated.
2. Reaction mixtures for these experiments were similar to those described in Table II except that cytochrome c was omitted, NADPH was present only in the sample cuvette, and SOD (when tested) was present in both cuvettes. Reaction rates were measured at 340 nm.
Neither the pellet nor supernate fraction alone oxidized NADPH in the presence of arachidonate. The rate of superoxide generation in the cell-free system reported here can account for 20-50% of the superoxide rate seenin intact cells stimulated with arachidonic acid. It is important to point out that these figures represent minimal estimates, since the cell-free activation system has not yet been optimized. In particular, the concentration of the soluble cofactor in this system is still limiting. This is not surprising since the final dilution of all cytoplasmic components in each reaction mixture was 100-fold compared with their concentrations in intact cells. The increase in superoxide generation observed when the amount of supernate was increased by 2'/2-fold undoubtedly reflects a decrease in this dilution factor to 1:40. Further increases in the concentration of the soluble component may result in even greater rates of superoxide production in the cell-free system.
The experiments with the CGD neutrophils failed to disclose any heterogeneity in this disorder, despite the fact that two different genetic forms of the disease were analyzed. In all cases the soluble component was normal and the particulate material was abnormal. This result suggests that the mutations in both forms ofthe disease affect some aspect ofthe membrane. The possibility still remains, however, that these mutations could affect either the oxidase molecule itself or components of the activation pathway that reside in the membrane.
